Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-03-16 Purchase | 2021-03-16 9:49 pm | Prometheus Biosciences Inc. | RXDX | Stenhouse Mark Chief Operating Officer | 14,000 | $19 | $266,000 | 14,000 (Direct) | View |
| 2020-04-03 Sale | 2020-04-06 4:41 pm | EXACT SCIENCES CORP | EXAS | Stenhouse Mark President, Cologuard | 11,948 | $56.69 | $677,332 | 54,926 (Indirect Direct) | View |
| 2020-02-27 Sale | 2020-02-28 4:39 pm | EXACT SCIENCES CORP | EXAS | Stenhouse Mark President, Cologuard | 1,051 | $80.27 | $84,364 | 26,663 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-23 Option Award | 2024-05-24 7:18 pm | N/A 2034-05-22 | Phathom Pharmaceuticals Inc. | PHAT | Stenhouse Mark Director | 28,000 | $0 | 37,000 (Direct) | View |
| 2023-06-16 Disposition | 2023-06-16 4:00 pm | N/A 2028-05-22 | Prometheus Biosciences Inc. | RXDX | Stenhouse Mark Chief Operating Officer | 497,792 | $0 | 0 (Direct) | View |
| 2023-06-01 Other | 2023-06-02 6:57 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | Stenhouse Mark Chief Operating Officer | 14,000 | $0 | 54,708 (Direct) | View |
| 2023-05-25 Option Award | 2023-05-30 7:01 pm | N/A 2033-05-24 | Phathom Pharmaceuticals Inc. | PHAT | Stenhouse Mark Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2022-12-09 Option Award | 2022-12-13 8:38 pm | N/A 2032-12-08 | Prometheus Biosciences Inc. | RXDX | Stenhouse Mark Chief Operating Officer | 43,896 | $0 | 60,527 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-27 4:50 pm | N/A 2032-05-24 | Phathom Pharmaceuticals Inc. | PHAT | Stenhouse Mark Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-05-20 Option Award | 2022-05-20 7:15 pm | 2025-05-20 2032-05-19 | Prometheus Biosciences Inc. | RXDX | Stenhouse Mark Chief Operating Officer | 86,582 | $0 | 86,582 (Direct) | View |
| 2021-11-14 Option Award | 2021-11-16 9:10 pm | N/A 2031-11-13 | Prometheus Biosciences Inc. | RXDX | Stenhouse Mark Chief Operating Officer | 70,371 | $0 | 70,371 (Direct) | View |
| 2021-05-21 Option Award | 2021-05-24 5:44 pm | N/A 2031-05-20 | Phathom Pharmaceuticals Inc. | PHAT | Stenhouse Mark Director | 12,500 | $0 | 12,500 (Direct) | View |
Ownership | 2021-03-11 9:29 pm | 2021-02-04 2028-05-22 | Prometheus Biosciences Inc. | RXDX | Stenhouse Mark Chief Operating Officer | 0 | $0 | 280,000 (Direct) | View |
| 2020-04-02 Exercise | 2020-04-06 4:41 pm | N/A N/A | EXACT SCIENCES CORP | EXAS | Stenhouse Mark President, Cologuard | 25,000 | $0 | 54,926 (Direct) | View |
| 2020-03-17 Option Award | 2020-03-19 4:34 pm | N/A 2030-03-16 | Phathom Pharmaceuticals Inc. | PHAT | Stenhouse Mark Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-02-26 Exercise | 2020-02-28 4:39 pm | N/A N/A | EXACT SCIENCES CORP | EXAS | Stenhouse Mark President, Cologuard | 3,262 | $0 | 26,663 (Direct) | View |
| 2020-02-14 Option Award | 2020-02-18 4:40 pm | N/A N/A | EXACT SCIENCES CORP | EXAS | Stenhouse Mark President, Cologuard | 25,568 | $0 | 40,039 (Direct) | View |